Generic and over-the-counter drugs company Stada has asked the German government to seek assurances from Ukraine that the company can continue operations
there even though it also does business in Russia.
In a March 21 letter to German Economy Minister Robert Habeck, Stada CEO Peter Goldschmidt said there was a risk Kyiv might withdraw the company's market
authorisation.
Stada "still has no longer-term certainty that we will be able to sell our products in Ukraine in the future," the letter said, with the subject line: "Please
prevent the exclusion of international pharmaceutical companies from the Ukrainian market." The Economy Ministry did not have an immediate comment on the letter.
Habeck promised investment guarantees for German companies during a trip to Ukraine on Tuesday (April 4) as part of his goal to speed up reconstruction in the
war-torn country.
Goldschmidt said restricting Stada's operations would be bad for Ukraine.
STADA has appointment Nigel Stephenson as General Manager UK with effect from 1 August 2023.
Based in Huddersfield, UK, Stephenson will report directly to STADA's Head of Western Europe and Germany, Stephan Eder.
He will take over from Rudolf Bär, who has successfully led the UK business for almost one year in addition to his responsibilities for STADA's Mid-Sized European
Markets.|
A dynamic and modern commercial leader with extensive experience in sales and marketing across Western, Central and Eastern Europe, and the UK in leading
pharmaceutical, consumer healthcare and fast-moving consumer goods companies.
He joins STADA from consumer healthcare leader Haleon, where he most recently served as General Manager Switzerland.
"With his strong people and results orientation, along with deep purpose-driven engagement, Nigel will support our UK team in realizing its full potential
through innovative and inclusive leadership," stated Eder.